[go: up one dir, main page]

Tanaka et al., 2018 - Google Patents

Incremental value of objective frailty assessment to predict mortality in elderly patients hospitalized for heart failure

Tanaka et al., 2018

Document ID
14459349202097538513
Author
Tanaka S
Kamiya K
Hamazaki N
Matsuzawa R
Nozaki K
Maekawa E
Noda C
Yamaoka-Tojo M
Matsunaga A
Masuda T
Ako J
Publication year
Publication venue
Journal of cardiac failure

External Links

Snippet

Background The impact of frailty on long-term prognosis in patients with heart failure (HF) remains unclear, and there is no simple and objective assessment for it. This study was performed to examine the association between frailty score and clinical outcome in elderly …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data

Similar Documents

Publication Publication Date Title
Tanaka et al. Incremental value of objective frailty assessment to predict mortality in elderly patients hospitalized for heart failure
Castellana et al. Physical frailty, multimorbidity, and all-cause mortality in an older population from southern Italy: results from the Salus in Apulia study
Parikh et al. Heart failure with preserved ejection fraction expert panel report: current controversies and implications for clinical trials
Kalyani et al. Hyperglycemia and incidence of frailty and lower extremity mobility limitations in older women
Morshedi-Meibodi et al. Heart rate recovery after treadmill exercise testing and risk of cardiovascular disease events (The Framingham Heart Study)
Nichols et al. Low skeletal muscle mass is associated with low aerobic capacity and increased mortality risk in patients with coronary heart disease–a CARE CR study
Ahmad et al. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure
Macchia et al. Unrecognised ventricular dysfunction in COPD
Soliman et al. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)
Forman et al. 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure
Narumi et al. The prognostic importance of objective nutritional indexes in patients with chronic heart failure
Freiberg et al. BMI vs. waist circumference for identifying vascular risk
Shah et al. Relation of short-term heart rate variability to incident heart failure (from the Multi-Ethnic Study of Atherosclerosis)
Di Chiara et al. Association between low education and higher global cardiovascular risk
US8361389B2 (en) Monitoring methods and apparatus
Qiu et al. Association between cardiorespiratory fitness and risk of type 2 diabetes: a meta‐analysis
Mishima et al. Self-reported physical activity and atrial fibrillation risk: a systematic review and meta-analysis
Istenes et al. Heart rate variability is severely impaired among type 2 diabetic patients with hypertension
Jensen et al. Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study
Pasqualini et al. Renal dysfunction predicts long‐term mortality in patients with lower extremity arterial disease
Everett et al. B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women
Carnethon et al. Correlates of heart rate recovery over 20 years in a population sample
Segar et al. Prefrailty, impairment in physical function, and risk of incident heart failure among older adults
AU2004305066A1 (en) Monitoring method and apparatus
Honda et al. Clinical implications of severe sarcopenia in Japanese patients with acute heart failure